Monterona, Alicia N.
HRN: 22-69-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/20/2023
CLINDAMYCIN 300MG (CAP)
10/20/2023
10/26/2023
PO
600mg
Q6
Infected Wound
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes